Merriman Curhan Ford Hires Veteran Biotechnology Analyst Edward H. Nash

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 5:30pm EDT

SAN FRANCISCO--(Business Wire)--
Merriman Curhan Ford Group, Inc. (NASDAQ:MERR) today announced
that it has hired Edward H. Nash as a senior biotechnology equity
research analyst and managing director. Nash will be based out of the
New York office.

   "Edward brings a high level of experience and seniority to our
firm as we aggressively revamp our health care practice," said Jon
Merriman, chief executive officer of Merriman Curhan Ford. "His
background is a great fit for our platform, and his skill set also
complements Panel Intelligence, our primary market research
subsidiary. I am very pleased to welcome him to the firm."

   Nash brings more than 10 years of experience as a biotechnology
analyst. Most recently he was a senior biotech analyst and equity
research principal at Stifel, Nicolaus & Co. Prior to Stifel he was a
biotech analyst at several firms, including Rodman & Renshaw, Commerce
Capital Markets, Ladenburg Thalmann & Co. and Lazard Freres & Co. He
holds an M.B.A. and an M.S. from the University of Miami and an M.P.H.
from the University of Alabama at Birmingham.

   About Merriman Curhan Ford

   Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm
focused on fast-growing companies and the institutions who invest in
them. The company offers high-quality investment banking, equity
research, institutional services, primary market research, corporate &
executive services, asset management and venture services, and
specializes in four growth industry sectors: CleanTech,
Consumer/Internet/Media, Health Care and Tech/Telecom. For more
information, please go to www.mcfco.com.

   Note to Investors

   This press release contains certain forward-looking statements
based on our current expectations, forecasts and assumptions that
involve risks and uncertainties. Forward-looking statements in this
release are based on information available to us as of the date
hereof. Our actual results may differ materially from those stated or
implied in such forward-looking statements, due to risks and
uncertainties associated with our business, which include the risk
factors disclosed in our Form 10-Q filed on August 11, 2008.
Forward-looking statements include statements regarding our
expectations, beliefs, intentions or strategies regarding the future
and can be identified by forward-looking words such as "anticipate,"
"believe," "could," "estimate," "expect," "intend," "may," "should,"
"will," and "would" or similar words. We assume no obligation to
update the information included in this press release, whether as a
result of new information, future events or otherwise. The Form 10-Q
filed on August 11, 2008, together with this press release and the
financial information contained herein, is available on our website by
going to www.mcfco.com and clicking on "Investor Relations."

Mandelbaum Partners
Shawn Simmons, 310-785-0810
shawn@mandelbaumpartners.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.